The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
A non-opioid pain medication made by Vertex Pharmaceuticals ... We've added you to our mailing list.
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...